Patients who have drug-resistant tuberculosis have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine.
More than 120 students took part in the Digital Agriculture Hackathon, sponsored by the Cornell Institute for Digital Agriculture and Entrepreneurship at Cornell.
More than 80% of global land area needed to maintain human well-being and meet biodiversity targets is at risk of conflict with human development, according to a new study led by the Cornell Lab of Ornithology.
Cornell researchers have the opportunity to take a long stride toward an alternative future full of possibility, with support from Global Cornell’s new Global Grand Challenge: The Future. On Jan. 29 Global Cornell opened what will be the initiative’s only call for proposals.
Applications are open for the Contribution Project, a program that grants $400 each to undergraduates with ideas for how to make a difference in the world.
Social entrepreneur Heather Henyon, MBA ’03, was honored with the 2023 Cañizares Award for Distinguished Alumni in International Business and Emerging Markets.
Structural insights into a potent antimalarial drug candidate’s interaction with a malaria parasite have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.
A new study, which brought together Cornell researchers, Cambodian fishers and Cambodian researchers, had study participants take photos that researchers then use to facilitate interviews and group discussions during which the subjects share their life experiences and perspectives.